Asthma and allergy vaccine - Vactech
Latest Information Update: 28 Sep 2020
At a glance
- Originator Vactech
- Class Virus-like particle vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Asthma; Hypersensitivity
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Allergy in Finland
- 28 Sep 2020 No recent reports of development identified for research development in Asthma in Finland
- 15 Aug 2016 Early research in Asthma in Finland (unspecified route)